Table 2.
Comparison of therapeutic response rates in the studied groups using the intention-to-treat approach and per-protocol analysis.
Proportion (%) of patients with cure at 8 weeks | ||||
---|---|---|---|---|
Analytical assumptiona | AmB group | GL group | OR (95% CI) | P |
(AmB versus GL) | ||||
Per protocol | 22/39 (56.4) | 25/37 (67.6) | 1.610 (0.632, 4.101) | 0.317 |
ITT | 22/50 (44.0) | 29/60 (48.3) | 1.91 (0.560, 2.530) | 0.650 |
GL: glucantime; AmB: liposomal amphotericin B; ITT: intention-to-treat; OR: odds ratio; CI: confidence interval.
aPer protocol: analysis excluding patients that were lost to follow up, ITT: analysis including patients lost to follow up throughout the study, who were considered to have experienced treatment failure.